Compounded Semaglutide Concerns, Sleep & Dementia, and Healthcare Post-Election
In this episode, Dr. Chi-Ming Chow welcomes listeners and introduces concerns surrounding compounded semaglutide, along with the link between sleep and dementia. He delves into recent study findings on daytime sleepiness and its implications for increased dementia risk. The episode discusses the ongoing controversies and changes related to work-life balance in the medical profession. Dr. Chow also provides insights into the healthcare outlook post-election, addressing key topics like the Affordable Care Act, drug pricing, and reproductive rights. The episode concludes with Dr. Chow's closing remarks and a preview of the next episode.
Key Points
- Compounded versions of semaglutide have been linked to numerous hospitalizations and deaths, raising concerns about their safety and regulation.
- Daytime sleepiness in older adults could signal a higher risk for motoric cognitive risk syndrome, which significantly increases the likelihood of developing dementia.
- A cultural shift in medicine is advocating for better work-life balance among physicians, challenging the traditional 'workaholic' mindset and addressing the negative impacts of burnout.
Chapters
0:00 | |
3:57 | |
7:24 | |
12:14 | |
16:07 |
Transcript
Loading transcript...
- / -